Literature DB >> 20854932

Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.

.   

Abstract

To evaluate strategies to reduce HIV-1 transmission through breastfeeding, a multicentre study including a nested randomized controlled trial was implemented in five research sites in West, East and South Africa (The Kesho Bora Study). The aim was to optimize the use of antiretroviral (ARV) drugs during pregnancy, delivery and breastfeeding to prevent mother-to-child transmission of HIV-1 (PMTCT) and to preserve the health of the HIV-1-infected mother. The study included long-term ARV treatment for women with advanced disease, and short-course ARV prophylaxis stopped at delivery for women with early disease. Women with intermediate disease participated in a randomized controlled trial to compare safety and efficacy of triple-ARV prophylaxis prolonged during breastfeeding with short-course ARV prophylaxis stopped at delivery. Between January 2005 and August 2008 a total of 1140 women were enrolled. This paper describes the study design, interventions and protocol amendments introduced to adapt to evolving scientific knowledge, international guidelines and availability of ARV treatment. The paper highlights the successes and challenges during the conduct of the trial. The Kesho Bora Study included one of the few randomized controlled trials to assess safety and efficacy of ARV prophylaxis continued during breastfeeding and the only randomized trial to assess maternal prophylaxis started during pregnancy. The findings have been important for informing international and national guidelines on MTCT prevention in developing countries where, due to poverty, lack of reliable and affordable supply of replacement feed and stigma associated with HIV/AIDS, HIV-infected women have little or no option other than to breastfeed their infants. (ISRCTN71468401).
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20854932     DOI: 10.1016/j.cct.2010.09.008

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  9 in total

1.  Formula-Feeding of HIV-Exposed Uninfected African Children Is Associated with Faster Growth in Length during the First 6 Months of Life in the Kesho Bora Study.

Authors:  Kirsten A Bork; Cécile Cames; Marie-Louise Newell; Jennifer S Read; Kossiwavi Ayassou; Faith Musyoka; Grace Mbatia; Amandine Cournil
Journal:  J Nutr       Date:  2017-01-25       Impact factor: 4.798

2.  Exclusive Breast-feeding Protects against Mother-to-Child Transmission of HIV-1 through 12 Months of Age in Tanzania.

Authors:  Karim P Manji; Christopher Duggan; Enju Liu; Ronald Bosch; Rodrick Kisenge; Said Aboud; Ronald Kupka; Wafaie W Fawzi
Journal:  J Trop Pediatr       Date:  2016-03-15       Impact factor: 1.165

3.  Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.

Authors: 
Journal:  Clin Infect Dis       Date:  2012-05-09       Impact factor: 9.079

4.  Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine.

Authors:  Rose Bosire; Carey Farquhar; Ruth Nduati; Kristina Broliden; Stanley Luchters; Philippe Van de Perre; Isabelle De Vincenzi; Michele Merkel; Veronicah Wachuka; Dorothy Mbori-Ngacha; Grace John-Stewart; Barbara Lohman-Payne; Marie Reilly
Journal:  Pediatr Infect Dis J       Date:  2018-03       Impact factor: 2.129

5.  Morbidity in relation to feeding mode in African HIV-exposed, uninfected infants during the first 6 mo of life: the Kesho Bora study.

Authors:  Kirsten A Bork; Amandine Cournil; Jennifer S Read; Marie-Louise Newell; Cécile Cames; Nicolas Meda; Stanley Luchters; Grace Mbatia; Kevindra Naidu; Philippe Gaillard; Isabelle de Vincenzi
Journal:  Am J Clin Nutr       Date:  2014-10-22       Impact factor: 7.045

Review 6.  Antiretroviral therapy in prevention of HIV and TB: update on current research efforts.

Authors:  Reuben Granich; Somya Gupta; Amitabh B Suthar; Caoimhe Smyth; David Hoos; Marco Vitoria; Mariangela Simao; Catherine Hankins; Bernard Schwartlander; Renee Ridzon; Brigitte Bazin; Brian Williams; Ying-Ru Lo; Craig McClure; Julio Montaner; Gottfried Hirnschall
Journal:  Curr HIV Res       Date:  2011-09       Impact factor: 1.581

7.  Infant feeding in the context of HIV: a qualitative study of health care workers' knowledge of recommended infant feeding options in Papua New Guinea.

Authors:  Lisa M Vallely; Angela Kelly; Martha Kupul; Ruthy Neo; Voletta Fiya; John M Kaldor; Glen Dl Mola; Heather Worth
Journal:  Int Breastfeed J       Date:  2013-06-07       Impact factor: 3.461

8.  Changes in body mass index and hemoglobin concentration in breastfeeding women living with HIV with a CD4 count over 350: Results from 4 African countries (The ANRS 12174 trial).

Authors:  Eric Nagaonlé Somé; Ingunn M S Engebretsen; Nicolas Nagot; Nicolas Y Meda; Roselyne Vallo; Chipepo Kankasa; James K Tumwine; Mandisa Singata; Justus G Hofmeyr; Philippe Van de Perre; Thorkild Tylleskär
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

9.  Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.

Authors:  Benn K D Sartorius; Matthew F Chersich; Mary Mwaura; Nicolas Meda; Marleen Temmerman; Marie Louise Newell; Timothy M M Farley; Stanley Luchters
Journal:  BMC Infect Dis       Date:  2013-11-06       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.